These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Promyelocytic leukemia nuclear bodies support a late step in DNA double-strand break repair by homologous recombination. Yeung PL; Denissova NG; Nasello C; Hakhverdyan Z; Chen JD; Brenneman MA J Cell Biochem; 2012 May; 113(5):1787-99. PubMed ID: 22213200 [TBL] [Abstract][Full Text] [Related]
4. Promyelocytic leukemia activates Chk2 by mediating Chk2 autophosphorylation. Yang S; Jeong JH; Brown AL; Lee CH; Pandolfi PP; Chung JH; Kim MK J Biol Chem; 2006 Sep; 281(36):26645-54. PubMed ID: 16835227 [TBL] [Abstract][Full Text] [Related]
5. Understanding the molecular pathogenesis of acute promyelocytic leukemia. Lo-Coco F; Hasan SK Best Pract Res Clin Haematol; 2014 Mar; 27(1):3-9. PubMed ID: 24907012 [TBL] [Abstract][Full Text] [Related]
6. Pml nuclear body disruption cooperates in APL pathogenesis and impairs DNA damage repair pathways in mice. Voisset E; Moravcsik E; Stratford EW; Jaye A; Palgrave CJ; Hills RK; Salomoni P; Kogan SC; Solomon E; Grimwade D Blood; 2018 Feb; 131(6):636-648. PubMed ID: 29191918 [TBL] [Abstract][Full Text] [Related]
7. Hsp90α regulates ATM and NBN functions in sensing and repair of DNA double-strand breaks. Pennisi R; Antoccia A; Leone S; Ascenzi P; di Masi A FEBS J; 2017 Aug; 284(15):2378-2395. PubMed ID: 28631426 [TBL] [Abstract][Full Text] [Related]
8. TRIB3 Promotes APL Progression through Stabilization of the Oncoprotein PML-RARα and Inhibition of p53-Mediated Senescence. Li K; Wang F; Cao WB; Lv XX; Hua F; Cui B; Yu JJ; Zhang XW; Shang S; Liu SS; Yu JM; Han MZ; Huang B; Zhang TT; Li X; Jiang JD; Hu ZW Cancer Cell; 2017 May; 31(5):697-710.e7. PubMed ID: 28486108 [TBL] [Abstract][Full Text] [Related]
9. PML/RARα-Regulated miR-181a/b Cluster Targets the Tumor Suppressor RASSF1A in Acute Promyelocytic Leukemia. Bräuer-Hartmann D; Hartmann JU; Wurm AA; Gerloff D; Katzerke C; Verga Falzacappa MV; Pelicci PG; Müller-Tidow C; Tenen DG; Niederwieser D; Behre G Cancer Res; 2015 Aug; 75(16):3411-24. PubMed ID: 26041820 [TBL] [Abstract][Full Text] [Related]
10. Identification of B94 (TNFAIP2) as a potential retinoic acid target gene in acute promyelocytic leukemia. Rusiniak ME; Yu M; Ross DT; Tolhurst EC; Slack JL Cancer Res; 2000 Apr; 60(7):1824-9. PubMed ID: 10766166 [TBL] [Abstract][Full Text] [Related]
11. Phase separation of PML/RARα and BRD4 coassembled microspeckles governs transcriptional dysregulation in acute promyelocytic leukemia. Zhang Y; Lou J; Liu Y; Jin P; Tan Y; Song H; Jin W; Wang D; Dong F; Wu S; Fang H; Chen S; Chen Z; Wang K Proc Natl Acad Sci U S A; 2024 Aug; 121(34):e2406519121. PubMed ID: 39136995 [TBL] [Abstract][Full Text] [Related]
12. The functional roles of PML nuclear bodies in genome maintenance. Chang HR; Munkhjargal A; Kim MJ; Park SY; Jung E; Ryu JH; Yang Y; Lim JS; Kim Y Mutat Res; 2018 May; 809():99-107. PubMed ID: 28521962 [TBL] [Abstract][Full Text] [Related]
13. Deneddylation of PML/RARα reconstructs functional PML nuclear bodies via orchestrating phase separation to eradicate APL. Shao X; Chen Y; Xu A; Xiang D; Wang W; Du W; Huang Y; Zhang X; Cai M; Xia Z; Wang Y; Cao J; Zhang Y; Yang B; He Q; Ying M Cell Death Differ; 2022 Aug; 29(8):1654-1668. PubMed ID: 35194189 [TBL] [Abstract][Full Text] [Related]
14. UBE1L is a retinoid target that triggers PML/RARalpha degradation and apoptosis in acute promyelocytic leukemia. Kitareewan S; Pitha-Rowe I; Sekula D; Lowrey CH; Nemeth MJ; Golub TR; Freemantle SJ; Dmitrovsky E Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3806-11. PubMed ID: 11891284 [TBL] [Abstract][Full Text] [Related]
15. The PML and PML/RARalpha domains: from autoimmunity to molecular oncology and from retinoic acid to arsenic. Andre C; Guillemin MC; Zhu J; Koken MH; Quignon F; Herve L; Chelbi-Alix MK; Dhumeaux D; Wang ZY; Degos L; Chen Z; de The H Exp Cell Res; 1996 Dec; 229(2):253-60. PubMed ID: 8986606 [TBL] [Abstract][Full Text] [Related]
16. cAMP signalling is decisive for recovery of nuclear bodies (PODs) during maturation of RA-resistant t(15;17) promyelocytic leukemia NB4 cells expressing PML-RAR alpha. Duprez E; Lillehaug JR; Naoe T; Lanotte M Oncogene; 1996 Jun; 12(11):2451-9. PubMed ID: 8649787 [TBL] [Abstract][Full Text] [Related]
17. A RA-dependent, tumour-growth suppressive transcription complex is the target of the PML-RARalpha and T18 oncoproteins. Zhong S; Delva L; Rachez C; Cenciarelli C; Gandini D; Zhang H; Kalantry S; Freedman LP; Pandolfi PP Nat Genet; 1999 Nov; 23(3):287-95. PubMed ID: 10610177 [TBL] [Abstract][Full Text] [Related]
18. Blockade of the ubiquitin protease UBP43 destabilizes transcription factor PML/RARα and inhibits the growth of acute promyelocytic leukemia. Guo Y; Dolinko AV; Chinyengetere F; Stanton B; Bomberger JM; Demidenko E; Zhou DC; Gallagher R; Ma T; Galimberti F; Liu X; Sekula D; Freemantle S; Dmitrovsky E Cancer Res; 2010 Dec; 70(23):9875-85. PubMed ID: 20935222 [TBL] [Abstract][Full Text] [Related]